Literature DB >> 18327517

[Hepatitis associated cryoglobulinemia].

S Pischke1, M Cornberg, M P Manns.   

Abstract

Cryoglobulins are immunoglobulins that precipitate at temperatures below 37 degrees C. Clinically cryoglobulinemia is manifested in a variety of symptoms on different organs. The most important clinical symptoms are fatigue, peripheral neuropathy and vasculitis associated skin lesions. Pathophysiologically cryoglobulinemia is based on a disturbed immunocascade with an elevated B-cell-activity. Often a cryoglobulinemia progresses smoothly to a Non-Hodgkin-Lymphoma. The main activator of a cryoglobulinemia is a Hepatitis C virus infection. Other causes for developing a cryoglobulinemia are rheumatological and haematological diseases. In the past cryoglubulinemia has predominantly been treated with plasmapheresis and immunosuppression, nowadays antiviral strategies are becoming more important. Cases of rapid worsening under therapy with interferon alpha have also been reported. A promising new option is the use of rituximab.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18327517     DOI: 10.1007/s00108-007-2014-7

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  39 in total

Review 1.  Extrahepatic manifestations of HCV infection: facts and controversies.

Authors:  A L Zignego; C Bréchot
Journal:  J Hepatol       Date:  1999-08       Impact factor: 25.083

2.  Association of HCV-related mixed cryoglobulinemia with specific mutational pattern of the HCV E2 protein and CD81 expression on peripheral B lymphocytes.

Authors:  Wolf Peter Hofmann; Eva Herrmann; Bernd Kronenberger; Christian Merkwirth; Christoph Welsch; Thomas Lengauer; Stefan Zeuzem; Christoph Sarrazin
Journal:  Blood       Date:  2004-08-15       Impact factor: 22.113

Review 3.  Hepatitis C virus-associated mixed cryoglobulinemia. Clinical manifestations, histopathological changes, mechanisms of cryoprecipitation and options of treatment.

Authors:  P Schott; H Hartmann; G Ramadori
Journal:  Histol Histopathol       Date:  2001-10       Impact factor: 2.303

4.  Increased risks of lymphoma and death among patients with non-hepatitis C virus-related mixed cryoglobulinemia.

Authors:  David Saadoun; Jérémie Sellam; Pascale Ghillani-Dalbin; Richard Crecel; Jean-Charles Piette; Patrice Cacoub
Journal:  Arch Intern Med       Date:  2006-10-23

5.  Cryoglobulinemia--a study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability.

Authors:  M Meltzer; E C Franklin
Journal:  Am J Med       Date:  1966-06       Impact factor: 4.965

6.  Antiviral treatment down-regulates peripheral B-cell CD81 expression and CD5 expansion in chronic hepatitis C virus infection.

Authors:  Eli Zuckerman; Aharon Kessel; Gleb Slobodin; Edmond Sabo; Daniel Yeshurun; Elias Toubi
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  Immunoadsorption apheresis (Selesorb) in the treatment of chronic hepatitis C virus-related type 2 mixed cryoglobulinemia.

Authors:  C Stefanutti; S Di Giacomo; M Mareri; F De Lorenzo; G D'Alessandri; F Angelico; A Bucci; A Musca; A Mammarella
Journal:  Transfus Apher Sci       Date:  2003-06       Impact factor: 1.764

Review 8.  Atypical clinical manifestations of hepatitis A.

Authors:  E R Schiff
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

9.  Efficacy of low-dose rituximab for mixed cryoglobulinemia.

Authors:  Marcella Visentini; Massimo Granata; Maria Luisa Veneziano; Federica Borghese; Maurizio Carlesimo; Fulvia Pimpinelli; Massimo Fiorilli; Milvia Casato
Journal:  Clin Immunol       Date:  2007-08-09       Impact factor: 3.969

Review 10.  Extrahepatic manifestations of chronic HCV infection.

Authors:  Alessandra Galossi; Riccardo Guarisco; Lia Bellis; Claudio Puoti
Journal:  J Gastrointestin Liver Dis       Date:  2007-03       Impact factor: 2.008

View more
  2 in total

1.  Cryoglobulins in nonalcoholic Fatty-liver disease: what is the association?

Authors:  Benjamin C Bryson; Paul Angulo
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-04

2.  [Viral arthritis and vasculitis].

Authors:  U Sixdorf; E Märker-Hermann
Journal:  Z Rheumatol       Date:  2016-11       Impact factor: 1.372

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.